ASRT - デポメッド (Assertio Therapeutics Inc.)

ASRTのニュース

   Assertio Holdings: Recent Breakout To Lead To Sustained Gains  2022/04/07 16:16:34 Seeking Alpha
   Assertio Holdings Inc. (NASDAQ: ASRT): Stock Plunge On The Way?  2022/03/28 11:30:00 Stocks Register
The trading price of Assertio Holdings Inc. (NASDAQ:ASRT) closed lower on Friday, March 25, closing at $2.60, -12.16% lower than its previous close. >> 5 Best Growth Stocks for 2022 << >> 5 Best Growth Stocks for 2022 << Traders who pay close attention to intraday price movement should know that it fluctuated between $2.56 … Assertio Holdings Inc. (NASDAQ: ASRT): Stock Plunge On The Way? Read More »
   Assertio Holdings Inc. (NASDAQ: ASRT): Why Investors Shouldn’t Ditch ASRT Stock In 2022  2022/03/23 11:00:00 Marketing Sentinel
In the last trading session, 1.02 million Assertio Holdings Inc. (NASDAQ:ASRT) shares changed hands as the company’s beta touched 1.50. With the company’s per share price at $2.72 changed hands at $0.0 or 0.00% during last session, the market valuation stood at $122.84M. ASRT’s last price was a discount, traded about -36.76% off its 52-week … Assertio Holdings Inc. (NASDAQ: ASRT): Why Investors Shouldn’t Ditch ASRT Stock In 2022 Read More »
   Assertio Holdings Inc. (NASDAQ:ASRT): -42.28% Off High, Can It Comeback?  2022/03/18 12:00:00 Marketing Sentinel
In last trading session, Assertio Holdings Inc. (NASDAQ:ASRT) saw 1.02 million shares changing hands with its beta currently measuring 1.46. Company’s recent per share price level of $2.72 trading at $0.2 or 7.94% at ring of the bell on the day assigns it a market valuation of $123.30M. That closing price of ASRT’s stock is … Assertio Holdings Inc. (NASDAQ:ASRT): -42.28% Off High, Can It Comeback? Read More »
   Assertio Holdings, Inc.''s (ASRT) CEO Daniel Peisert on Q4 2021 Results - Earnings Call Transcript  2022/03/09 17:44:06 Seeking Alpha
   Assertio Holdings, Inc. to Report Fourth Quarter and Full Year 2021 Financial Results Before the Opening of Markets on Wednesday, March 9, 2022  2022/03/02 14:05:00 GlobeNewswire
LAKE FOREST, Ill., March 02, 2022 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT) today announced that it will release fourth quarter and full year 2021 financial results on Wednesday, March 9, 2022, before the open of markets. Following the release of its financial results, Assertio’s management will host a live webcast of the earnings conference call at 9:00 a.m. eastern time.
   Assertio Holdings Inc. (ASRT) Worth Considering For The Next Few Weeks  2022/02/26 14:30:00 Stocks Register
Assertio Holdings Inc. (NASDAQ:ASRT) concluded the trading at $2.37 on Friday, February 25 with a rise of 3.95% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $2.28 and 5Y monthly beta was reading 1.66 with its price kept floating in the … Assertio Holdings Inc. (ASRT) Worth Considering For The Next Few Weeks Read More »
   NASDAQ: ASRT Investor Alert: Investigation Concerning Possible Wrongdoing at Assertio Holdings, Inc.  2022/02/25 16:15:00 SBWire
An investigation on behalf of investors in Assertio Holdings, Inc. (NASDAQ: ASRT) shares over potential wrongdoing at Assertio Holdings, Inc. was announced. San Diego, CA -- ( SBWIRE ) -- 02/25/2022 -- An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Assertio Holdings, Inc. Investors who purchased shares of Assertio Holdings, Inc. (NASDAQ: ASRT) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Assertio Holdings directors breached their fiduciary duties and caused damage to the company and its shareholders. Lake Forest, IL based Assertio Holdings, Inc., a commercial pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Assertio Holdings, Inc. reported that its annual Total Revenue declined from $229.5 million in 2019 to $106.27 million in 2020, and that its Net Loss declined from $217.2 million in 2019 to $28.14 million in 2020.
   Is Assertio Holdings Inc. (NASDAQ: ASRT) A Top Momentum Pick?  2022/02/12 13:00:00 Stocks Register
Assertio Holdings Inc. (NASDAQ:ASRT) price on Friday, February 11, fall -5.26% below its previous days close as a downside momentum from buyers pushed the stocks value to $2.52. A look at the stocks price movement, the close in the last trading session was $2.66, moving within a range at $2.50 and $2.72. The beta value Is Assertio Holdings Inc. (NASDAQ: ASRT) A Top Momentum Pick? Read More »
   Thinking about buying stock in Exterran Corp, Microbot Medical, Nordstrom, Telefonica S.A., or Assertio Holdings?  2022/01/24 13:30:00 Benzinga
NEW YORK , Jan. 24, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for EXTN, MBOT, JWN, TEF, and ASRT. Full story available on Benzinga.com
   Will Shareholder Love To Invest in This Stock? NovaBay Pharmaceuticals, Inc. (AMEX:NBY), Assertio Holdings, Inc. (NASDAQ:ASRT)  2021/08/12 00:22:18 Stock Equity
NovaBay Pharmaceuticals, Inc. (AMEX:NBY) with the stream of -1.78% also noticed, India Assertio Holdings, Inc. (NASDAQ:ASRT) encountered a rapid change of -3.21% in the last hour of Wednesdays trading session. The post Will Shareholder Love To Invest in This Stock? NovaBay Pharmaceuticals, Inc. (AMEX:NBY), Assertio Holdings, Inc. (NASDAQ:ASRT) appeared first on Stocks Equity .
   Assertio Holdings, Inc. (ASRT) CEO Dan Peisert on Q2 2021 Results - Earnings Call Transcript  2021/08/06 02:39:04 Seeking Alpha
   Gabapentin Market 2021 Precise Outlook Pfizer, Assertio Therapeutics, TEVA, Mylan  2021/07/29 12:03:15 OpenPR
The Global Gabapentin Market Research Report 2021-2027 is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand, and supply data (as applicable). The research analysts
   Traders cant brush off this: Assertio Holdings, Inc. (NASDAQ:ASRT), Kelso Technologies Inc. (AMEX:KIQ)  2021/07/25 21:03:41 Stock Equity
Assertio Holdings, Inc. (ASRT) with the stream of -0.79% also noticed, India Kelso Technologies Inc. (KIQ) encountered a rapid change of -6.06% in the last hour of trading session. Assertio The post Traders cant brush off this: Assertio Holdings, Inc. (NASDAQ:ASRT), Kelso Technologies Inc. (AMEX:KIQ) appeared first on Stocks Equity .
   The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street  2021/07/20 12:19:55 Benzinga
Here''s a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 19) Cytokinetics, Incorporated (NASDAQ: CYTK ) ( announced topline results from Cohorts 1 and 2 of the Phase 2 study of CK-274 in obstructive outflow disease in hypertrophic cardiomyopathy) Forward Pharma A/S (NASDAQ: FWP ) ResMed Inc. (NYSE: NRMD) Legend Biotech Corporation (NASDAQ: LEGN ) Moderna, Inc. (NASDAQ: MRNA ) ( extended gains on recent momentum) Down In The Dumps (Biotech Stocks Hitting 52-week Lows July 19) 4D pharma plc (NASDAQ: LBPS ) Adaptimmune Therapeutics plc (NASDAQ: ADAP ) Adverum Biotechnologies, Inc. (NASDAQ: ADVM ) Aerovate Therapeutics, Inc. (NASDAQ: AVTE ) (IPOed June 30) Agile Therapeutics, Inc. (NASDAQ: AGRX ) Allena Pharmaceuticals, Inc. (NASDAQ: ALNA ) Alzamend Neuro, Inc. (NASDAQ: ALZN ) Aptose Biosciences Inc. (NASDAQ: APTO ) ARCA biopharma, Inc. (NASDAQ: ABIO ) Ascendis Pharma A/S (NASDAQ: ASND ) Assembly Biosciences, Inc.

calendar